Dense intramembranous deposit disease: new pathologic features

Kidney International
|April 1, 1984
PubMed

Insights

Dense intramembranous deposit disease presents with varied kidney pathologies, including membranoproliferative and necrotizing glomerulonephritis. Diagnosis relies on electron microscopy due to atypical light microscopy findings.

Area of Science:

  • Nephrology
  • Pathology
  • Immunology

Background:

  • Dense intramembranous deposit disease (DIDD) is a rare kidney disorder.
  • Its presentation can mimic other forms of glomerulonephritis, complicating diagnosis.

Purpose of the Study:

  • To describe the pathologic and clinical features of 16 patients with DIDD.
  • To evaluate diagnostic challenges and support renaming the condition.

Main Methods:

  • Light microscopy, immunofluorescence, and ultrastructural (electron microscopy) analysis of kidney biopsies.
  • Clinical data including presenting symptoms and laboratory findings were reviewed.

Main Results:

  • Histologic findings varied, including membranoproliferative glomerulonephritis (MPGN) and focal segmental necrotizing glomerulonephritis (FSNGN).
  • Dense intramembranous deposits were not always visible on light microscopy, necessitating electron microscopy for definitive diagnosis.
  • Clinical features ranged from nephrotic to nephritic syndromes; depressed C3 levels were noted in MPGN subtypes.

Conclusions:

  • DIDD exhibits diverse histological presentations, challenging light microscopy diagnosis.
  • Electron microscopy is crucial for identifying characteristic dense intramembranous deposits.
  • The term 'dense intramembranous deposit disease' is proposed to encompass these variable features, replacing 'membranoproliferative glomerulonephritis type II'.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...